Summary
We have previously produced lines of rats transgenic for HLA-B27 and human 32-microglobulin (h32m) that develop a progressive inflammatory disease sharing many clinical and histologic features with the B27-associated human spondyloarthropathies, including gut and male genital inflammation, arthritis, and psoriasiform skin lesions. Other transgenic lines that express lower levels of B27 and h/~zrn remain healthy. To investigate the cellular basis for the multisystem inflammatory disease in these rats, we transferred lymphoid cell populations from disease-prone transgenic lines to irradiated disease-resistant transgenic and nontransgenic recipients. In recipients of cells from two different disease-prone lines, successful transfer required engraftment of bone marrow cells. Transfer of disease with fetal liver cells suggested that neither mature effector cells nor active disease in the donors was necessary for induction of disease in the recipients. Remission of the spontaneous disease in irradiated transgenic rats was induced by engraftment of nontransgenic bone marrow. These results suggest that the expression of HLA-B27 in bone marrow-derived cells alone is sufficient for the development of B27-associated disease, and that disease transfer requires engraftment of a bone marrow precursor cell for which mature cells in spleen or in lymph node cannot substitute.
S
everal human diseases show association and genetic linkage with class I or II alleles of the HLA complex (1) . Among the most striking of these associations is that of the class I allele HLA-B27 with the disorders termed spondyloarthropathies, in which there is inflammatory involvement of axial and peripheral joints, gastrointestinal and genitourinary tracts, skin, eye, and heart (summarized in reference 2). For most HLA-associated disorders, it has not been determined whether the associated alleles participate directly in disease pathogenesis. However, for the HLA-B27-associated spondyloarthropathies, the development of similar disease in transgenic rats expressing HLA-B27 has provided strong evidence for direct participation by the B27 molecule. Rats of two transgenic lines, 21-4H and 33-3, each hemizygous for a transgene locus bearing genes encoding HLA-B*2705 and human 82-microglobulin (hB2m), 1 uniformly develop a progressive inflammatory disease (2, 3) . The major features of this disease include chronic diarrhea resulting from gastrointestinal inflammation, peripheral and axial arthritis, psoriasiform skin and nail changes, and male genital inflammation. In a third 1 Abbreviations used in this ~tn'r: BM, bone marrow; FL, fetal liver; hBzm, human 32-microglobulin. line, 21-3, similar disease develops in rats that are homozygous for the transgene locus, whereas the hemizygotes remain healthy. Rats that are either hemi-or homozygous for the transgene loci of the 21-4L and 25-6 lines, which bear fewer copies of the transgenes than the 21-4H, 33-3 and 21-3 lines, have remained uniformly healthy (3) . All five lines bear the same genomic HLA-B*2705 and h~2m constructs, differing with respect to the transgenes only in the numbers of copies and levels of expression (2, 3) .
Because the histologic appearance of the lesions suggested strongly that the disease in rats is immune mediated, and because an immune pathogenesis is also suspected in most of the B27-associated disease manifestations in humans (4, 5), we sought to identify cells of the immune system that could transfer the disease induced by the B27 transgene. Here we report the results of these cell transfer experiments.
Materials and Methods
Animals. The transgenic rat lines 21-4L, bearing 6 copies each of the HLA-B*2705 and hB2m genes; 21-4H, bearing 150 copies of the B'2705 gene and 90 copies of the hB2m gene; and 33-3, bearing 55 copies of the B'2705 gene and 66 copies of the hB2m gene, were produced and maintained in our animal colony as previously described (2) . Nontransgenic LEW and F344 rats were pur-chased from Charles River, Inc. (Wilmington, MA). In September 1992, after many of the experiments involving the 21-4H and 21-4L lines had been carried out, we became aware that Charles River, Inc., had provided us with LEW breeding stock in 1991 that was contaminated with genes from an outbred line. Typing by hemagglutination for three RBC alloantigenic systems (RT2, RT3, and RTS) (6, 7) and for MHC haplotype (RT1) indicated that some rats of the 21-4L line carried a non-LEW RT2 allele, but all were homozygous for the expected LEW alleles at RTI, RT3, and RTS.
Some rats of the 21-4H line were found to carry a non-LEW RT/ haplotype (RT/'), but all were homozygous for the expected LEW alleles at RT2, RT3, and RTS. Rats of the 33-3 line showed only F344 alleles at four out of four unlinked loci typed serologically, and also at 10 out of 10 unlinked loci identified by microsatellite DNA polymorphisms, as described (8) . The 33-3 line was therefore likely to be authentically inbred on the F344 background.
Celt Suspensions. Single cell suspensions were prepared from bone marrow (BM), spleen, peripheral or mesenteric LN, or blood, as described (9) . Fetuses from time-mated pregnant females were harvested at various gestational points (presence of vaginal sperm taken as day 0). Single cell suspensions of fetal liver (FL) cells were made by disruption of minced fetal liver with a Pasteur pipette in 0.5 ml Dulbecco's PBS and filtration through nylon mesh before counting and injection. The HLA-B27 transgene status of the fetuses was determined by dot-blot hybridization of genomic DNA, as described (2) .
Cell Transfers. Recipients were either sublethally (300, 500, or 750 rad) or lethally (950, 1,050, or 1,350 tad) irradiated at 70 rad/min from a 137Cs source (Gammacell 40; Atomic Energy of Canada, Ltd., Kanala, Ont., Canada), 2-36 h before reconstitution. All cell suspensions were injected intravenously through the external jugular vein under ether anesthesia. Single cell suspensions prepared from individual FL were injected into individual recipients. Lethally irradiated nontransgenic F344 recipients of 33-3 LN cells also received a rescuing inoculum of 3 x 107 FL cells from day 16 nontransgenic syngeneic fetuses.
Clinical Evaluation. Recipients were monitored five times per week for chronic diarrhea, arthritis, and skin changes developing after or persisting beyond the first month after irradiation. The severity of diarrhea, arthritis, and skin changes was given a daily severity score of 0-4 each. The average daily total of these scores was calculated each week, with a maximum of 12, and the average of these weekly scores for each rat for the first 3 mo after the onset of disease was used as an index of disease severity. In all passive transfer experiments, control rats were observed past the time of latest onset of disease in affected rats. Fatal cachexia beyond the first month after irradiation was considered a consequence of the inflammatory disease manifestation, since in preliminary studies the radiation doses termed lethal (950-1,350 tad) were uniformly fatal within 3 wk in unreconstituted rats.
Flow Cytometry Analysis. Single and two-color flow cytometry were carried out as described (3), with some modifications. The following mouse mAb and their specificities were used, references for which are cited in (3): B1.23.2, IgG2a, monomorphic HLA-B and -C; R73, IgG1, rat TCR-o#3 C region;W3/25, IgG1, rat CD4; OX8 IgG1, rat CD8~ chain; OX33, IgG1, B cell-specific epitope of rat CD45; and OX19, IgG1, rat CD5. The mAb 3.2.3, IgG1, recognizing NKP-P1, a rat NK cell-specific surface protein (10) , and OX-42, IgG2a, recognizing rat C3b receptor (11) were also used. Irrelevant IgG2a and IgG1 mAb served as negative controls. All procedures were carried out at 4~ in DPBS containing 4% FCS and 0.05% sodium azide (staining buffer). For single color direct fluorescence, cells were preincubated 20 min in 50 #1 staining buffer containing 20% rat serum before addition of 50 #1 staining buffer containing directly conjugated FITC-B1. 23 Histopathology and Immunocytochemistry. These were carried out as described (2, 3) . In addition to the mAb listed above, HC-10, mouse IgG2b, specific for HLA-B H chain (12) , was also used for immunocytochemistry.
Results
Transfer of Disease to Transgenic 21-4L Rats. We initially assumed that the presence of HLA-B27 on nonhematopoietic cells within the target tissues of the disease, as well as on hematopoietic cells, might be important for disease expression. Therefore, rats of the disease-resistant B27 transgenic 21-4L line were used as recipients for cell suspensions from sick donor rats of the 21-4H disease-prone line ( Table 1) . Transfer of BM cells, alone or mixed with spleen cells, to sublethally irradiated (500-750 rad) recipients was associated in 11 of the 18 cases with persistent diarrhea starting 2-5 wk after transfer (group 1A, i.e., group A, Table 1 ). 10 recipients also later developed skin or nail changes resembling the spontaneous disease, and one recipient developed arthritis. In this first group of recipients, the number of BM cells injected ranged from 0.75 to 9 x 10 s per recipient with no clear correlation between cell dose and the incidence or severity of disease in the recipients. In most subsequent experiments, a standard dose of 10 s BM cells was used. After lethal irradiation (1,050 rad) and transplantation of 21-4H BM, 12 out of 12 21-4L recipients developed disease (group 1E) that was earlier in onset and more severe than that seen in the sublethally irradiated 21-4L recipients. These results indicated a significant influence of the radiation dose on the efficacy of disease transfer.
Histologic study of four of the sick recipients after 4-18 wk of disease showed mucosal inflammation diffusely distributed throughout the colon in all four rats and more focally distributed in the small intestine and stomach. Lesions were similar to those of the spontaneous disease (2), consisting mainly of mononuclear infiltration of the lamina propria, crypt epithelial hyperplasia, and loss of mucincontaining cells (Fig. 1 A) . In the more severe cases, crypt abscesses were present. No vasculitic lesions were seen. Skin (Fig. 2 A) and nail changes similar to the findings in the spontaneous disease were also present, consisting of epidermal hyperplasia and hyperkeratosis with dermal inflammation and perifolliculitis. Glossitis with histologic characteristics similar to that seen in the skin was present in three of the four recipients examined. This finding is also present in the spontaneous disease (our unpublished results). No liver abnormalities were seen in any of the four rats examined. In contrast with these results observed with BM, and particnlarly in contrast with the severe disease seen in recipients of BM plus spleen cells (group 1A), transfer of spleen or LN cells alone to sublethally irradiated recipients had an almost negligible clinical effect. Only one of eight spleen cell recipients and one of seven LN cell recipients developed any sign of disease, and this was confirmed to alopecia beginning 22 and 31 wk, respectively, after irradiation and cell transfer (groups 1B and C). One of these two recipients was examined histologically and showed dermal perifoUiculitis but no epidermal hyperplasia or inflammation. The colonic mucosa was normal. This result suggested that engraftment by BM stem cells may be required for transfer of disease. Since spleen contains a small population of hematopoietic stem cells (13) , if these could be successfully engrafted, it might be expected that disease would ensue. This prediction was borne out by the finding that six of six lethally irradiated 21-4L recipients of 21-4H spleen cells developed overt disease (group 1F). Disease in this group was milder and later in onset than that of comparable recipients of BM, as might be expected if disease was dependent upon stem cell engraftment and if the number of transferred stem cells was lower. Sublethally and lethally irradiated 21-4L recipients of control 21-4L or nontransgenic LEW cells remained healthy throughout the 13-60-wk period of observation (groups 1D, G, and H). Flow cytometry of spleen and PBM cells at 7-35 wk after transfer showed a population with high B27 surface expression in recipients that developed disease (Fig. 3 C, fluorescence intensity >103 ), similar to a population present in the 21-4H donors (Fig.  3 A) , whereas both the 21-4L recipients of 21-4L BM cells (group 1D, data not shown) and the 21-4L recipients that remained healthy after receiving 21-4H BM (group 1A, Fig.  3 D) showed a typical 21-4L pattern of B27 surface expression (Fig. 3 B) .
Transfer of Disease to Nontransgenic Recipients. The results obtained with the 21-4L recipients suggested that the recipients developing disease were largely repopulated by donor-derived hematopoietic cells after irradiation. However, the role of B27 expression in recipient cells not derived from BM remained undefined. Immunohistochemistry of the lesions in animals exhibiting the spontaneous disease had consistently shown B27 expression predominantly restricted to lymphoid cells, with negligible staining for B27 on gut epithelial cells (3). This suggested that disease induction might depend on B27 expression in lymphoid cells alone. Experiments were therefore performed in which 21-4H, 21-4L, 33-3, or nontransgenic F344 BM cells were transferred to lethally irradiated, sex-and strain-matched, nontransgenic LEW or F344 rats.
Recipients of 21-4L or nontransgenic F344 BM cells recovered completely from the effects of irradiation and remained healthy during an observation period of 6-77 wk after transfer (Tables 2 and 3 , groups 2G and 3G, Figs. 1 B and 2 C) . In contrast, all 21 LEW recipients of 21-4H BM cells and all 42 F344 recipients of t>0.5 x 10 s 33-3 BM cells developed persistent diarrhea and/or skin changes within 2-29 wk (groups 2D and 3C, median of 4 and 6 wk, respectively). Arthritis occurred in a total of seven animals, six of them LEW. Fatal cachexia was common in the LEW recipients (8 of 17 within 4 mo), but occurred in only one of the F344 recipients. Histologic lesions similar to those of the spontaneous disease and of the 21-4L recipients of 21-4H BM were present in the gut (data not shown), skin (Fig. 2 B) arthritic joints (Fig. 2 D) . On flow cytometry, BM cells from recipients of transgenic BM were predominantly B27 + (Fig. 
4, A-C). Spleen, LN, and PBMC showed surface expression
of B27 in all subpopulations of lymphoid cells examined, including cells displaying TCR-ot/B, CD4, CD8, CD5, NKPPl, and the B cell-specific epitope of CD45 ( Fig. 5 and data not shown). A consistent finding was the presence of a population of donor-derived non-T cells that were B27bns h', CD4 dim in the recipients that developed disease (Fig. 5, A and B). The proportion of these cells, which display monocytemacrophage morphology and stain with the mAb OX-42, increased with disease progression (data not shown). This was correlated with absolute monocytosis evident on blood smears of sick recipients, and also present in spontaneous disease (our unpublished observations). Immunohistochemistry of colonic lesions from nontransgenic recipients of BM cells from either 33-3 or 21-4H donors showed that the cells infiltrating the lamina propria were predominantly B27 § (data not shown), suggesting a direct role for donor-derived cells in the inflammatory lesions.
In comparison with the lethally irradiated LEW recipients of 21-4H BM cells, sublethally irradiated recipients showed disease of later onset and lesser severity (group 2A), similar to the patter seen with 21-4L recipients (group 1A). In addi- Dot plots were obtained for cells with mononuclear morphology, as defined by light scatter. Quadrants were defined by background staining with control tion, recipients with mild or absent disease manifestations showed a low proportion of B27 + PBM and BM cells, which indicated poor engraftment of donor marrow (Fig.  4 D) . Furthermore, none of the sublethally irradiated F344 recipients of 33-3 BM developed disease during 6 mo of observation (group 3A). In this strain, which is characterized by lower radiosensitivity than the LEW strain (data not shown), none of the 6 F344 recipients that had been irradiated at 300 tad, and only 7 of 12 recipients that had been irradiated at 750 tad, showed any B27 + PBM. The proportion of donor cells in these engrafted recipients was lower than in the comparably irradiated group of LEW recipients of21-4H BM (16 +_ 12% vs 44 + 14%). Three of the positively engrafted recipients developed chronic diarrhea beginning more than 8 mo after transfer.
TransJer of Spleen and LN Cells to Nontransgenic Recipients.
To further examine the need for stem cell engraftment in the transfer of disease, 21-4H and 33-3 spleen and LN cells were also transferred into sublethally or lethally irradiated nontransgenic recipients. None of the sublethally irradiated recipients of 33-3 cells developed any disease manifestation mAb. The numbers in each quadrant are the percentage of total cells represented by that quadrant. Numbers in parenthesis refer to the CD4 dim population displaying morphology and surface markers characteristic of monocytes.
up to 44 wk after transfer (group 3B), and only 1 of 14 sublethally irradiated recipients of 21-4H cells developed diarrhea, with typical histological lesions of enterocohtis (groups 2B and C). 5 of these 14 recipients also developed alopecia 14-22 wk after transfer with histological lesions restricted to perifoUiculitis, as previously seen in similarly irradiated 21-4L recipients. The recipients in these groups showed poor engraftment of the transgenic marrow ceils except for the one of spleen cells that developed chronic diarrhea (Fig. 4,  E and F) . Nonetheless, between 3 and 22% of T lymphocytes in peripheral blood or LN were of donor origin when examined 11-45 wk after transfer, indicating that the donor lymphocytes were not completely rejected. After lethal irradiation, three of four recipients of 21-4H spleen ceils and two of four recipients of 33-3 spleen cells developed disease that was milder overall than that seen after BM transfer (groups 2F and 3E). None of five recipients of 33-3 LN cells developed any disease manifestation up to 19 wk after transfer (group 3F). In all these groups, the transfer of disease consistently correlated with BM engraftment (Fig. 4 F) and with the presence of B27bag ht, CD4 aim monocytic cells in peripheral blood, whereas in the recipients that remained healthy, the CD4 d~ cells were host derived (compare C and D in Fig. 5 ). 
Transfer of Disease with FL

Nontransgenic BM Ameliorates Disease in 33-3 Recipients.
The foregoing results suggested that BM-derived precursor cells with the capacity to develop into cells with high expression of HLA-B27 are necessary for disease development in otherwise normal rats. If this were so, it might be expected that the spontaneous disease would be ameliorated by reconstitution with nontransgenic BM. To test this prediction, we treated 10 33-3 rats that had advanced disease with lethal irradiation (950 rad) followed by reconstitution with either nontransgenic BM or 33-3 BM (Fig. 6 ). All five recipients of 33-3 BM developed an exacerbation of diarrhea and skin lesions within a few weeks of transfer and died within 14 wk. In contrast, the five recipients of nontransgenic BM showed prompt improvement. Skin lesions and diarrhea disappeared 1613 Breban et al. completely in all five recipients after 8 wk. Two of these later developed an unexplained cachexia that was fatal 14 and 18 wk after transfer, but the remaining three all survived at least 9 mo after transfer free of clinical disease. Flow cytometry showed almost complete absence of B27 + cells in the BM (Fig. 4/-/) , blood, and peripheral lymphoid organs (data not shown). Histological examination of the gut showed only mild evidence of inflammation and scarring of the colon in the group reconstituted with nontransgenic BM (Fig. 1 D) , whereas the group receiving 33-3 BM showed typical severe lesions (data not shown). One of the two rats replaced with normal F344 BM that died spontaneously showed hepatic abnormalities consisting of fatty degeneration with a nonspecific granulomatoid reaction, probably secondary to infection. The liver of the other rat was normal except for rare, mild periductal mononuclear cell infiltration that is also occasionally seen in the spontaneous disease (data not shown).
Discussion
Disease Transfer and the Requirement for Bone Marrow Engraftment. Gut, skin, and joint disease in the recipients was induced by transfer of BM cells from the disease-prone 21-4H and 33-3 lines but not from the disease-resistant 21-4L line or from nontransgenic donors. In view of the correlation between disease susceptibility and high levels of B27 expression (3), this suggests strongly that the disease susceptibility of the 21-4H and 33-3 lines can be attributed to expression of high levels of B27 in one or more populations of BM-derived cells. Although the results with whole BM cells did not exclude the possibility that transfer of disease required cotransfer of mature effector cells (14) , subsequent experiments indicated that irradiated nontransgenic recipients of T cell--depleted BM (our unpublished findings) or FL cells from donors of disease-prone lines also developed inflammatory disease similar to that occurring spontaneously in the donor lines. It thus appears that hematopoietic precursor cells from premorbid rats of the disease-prone lines are sufficient to confer disease susceptibility in an otherwise nontransgenic environment.
In contrast to these results with BM and FL cell transfer, comparable numbers of spleen or LN cells injected into similarly irradiated recipients either induced less severe pathologic manifestations, almost exclusively limited to late perifolliculitis in the case of sublethally irradiated recipients, or had no pathological effect. These observations predicted that transfer of disease, particularly gut and joint disease, requires engraftment of BM stem cells in the recipients, and this prediction was supported by immunofluorescence analysis of BM and peripheral lymphoid cells from the various recipients. Because spleen or LN cells in the absence of BM engraftment failed to transfer disease, the findings further suggest a necessary role played by BM-derived hematopoietic precursors for which cells from peripheral lymphoid organs such as mature lymphocytes cannot readily substitute. Because of their high levels of expression of HLA-B27 in the disease-prone transgenic lines and also because of their involvement in MHCdependent immune responses, BM-derived APC from the monocytic or dendritic cell lineages are likely to play such a role. Evidence for this idea was provided by the observation that the incidence and progression of disease in the recipients correlated with the accumulation of a donor-derived monocytic population. Recovery from disease observed in 33-3 rats after replacement with nontransgenic BM may have been linked to this same population of precursor cells, although this was not formally demonstrated. Although it is conceivable that donor cells were rejected by the nontransgenic recipients in proportion to the level of expression of B27, such that spleen or LN cells showed less efficiency in transferring disease than the more immature cells provided by BM or FL cells, this was unlikely to happen in the 21-4L recipients, and the long-term persistence of mature B27 donor lymphocytes regularly observed in the blood of nontransgenic recipients of 21-4H or 33-3 LN or spleen cells also argues against this possibility.
Although a BM-derived nonlymphocyte population appears to be necessary for disease transfer, it is likely that T lymphocytes are also essential to the disease pathogenesis, since athymic nude rats bearing the 33-3 transgene locus fail to develop inflammatory disease unless reconstituted with T cells, even though BM cells from these nude rats can transfer disease to irradiated F344 recipients (our unpublished results).
Differences between the Spontaneous and Transferred Disease. The transferred disease bore dose clinical and histologic resemblance to the spontaneous disease, but with some differences. The most striking of these was the absence in the transfer recipients of male genital inflammation, which is a prominent part of the spontaneous disease. This finding suggests that the inflammatory genital disease is dependent upon a radiosensitive tissue, most likely sperm, which were uniformly absent from recipient testis and epididymis. Arthritis was less frequent in the transfer recipients than would have been predicted from the spontaneous disease, particularly in the recipients of 33-3 cells. The reason for this is unclear, but may be related to an effect of irradiation, since arthritis disappeared after irradiation in the 33-3 recipients of 33-3 BM and did not return. Finally, skin lesions in the transfer recipients tended to occur earlier in relation to the other findings than was the case in the spontaneous disease.
Differences between the Transferred Disease and GVHI~ Like B27-associated disease, GVHD in the rat can cause inflammatory lesions of the gut, skin, and joints (15) (16) (17) . It was therefore of concern, especially after genetic contamination of the 21-4H line was identified, that BM cells from these donors might have actually induced a form of GVHD that we took for passively transferred B27-associated disease. This seems unlikely for several reasons. First, the clinical and histologic appearance and the time course of both the spontaneous and passively transferred disease in the B27 rats differ substantially from that described for either acute or chronic GVHD in the rat. For example, the prominent hepatic and salivary gland abnormalities, vasculitis and pulmonary fibrosis of GVHD, are not found in the B27-associated disease. Colonic lesions are lacking in chronic GVHD in the rat but are a consistent and prominent feature of B27-associated disease; and the scleroderma-like skin changes of chronic GVHD are not found in the B27-associated disease, the B27-associated skin lesions being instead hyperplastic. Second, reproducible disease transfer was obtained with both 21-4H and 33-3 donors, the latter of which showed no evidence of genetic contamination. Third, the nontransgenic parents of the 21-4H donors in later transfers were all authentic LEW males, and hence there was no immunologic basis for GVHD in the nontransgenic LEW recipients of cells from these donors. Fourth, LN cells, which are usually potent inducers of GVHD (18) , were much less efficient in inducing disease manifestations than cells lacking mature T lymphocytes such as FL cells. Fifth, disease transfer with FL cells segregated perfectly with the B27 status of the 21-4H fetal donors (groups 2E and H), and independently of variations in genetic background (our unpublished observations). Therefore, despite the potential complication presented by the genetic contamination of the LEW lines, the data strongly suggest that the transferred disease is a B27 transgene-associated phenomenon, irrespective of the genetic background.
Comparisons with other Disease Transfer Models. The passive transfer of disease in the B27 transgenic rats bears similarity to studies of the BB/W rat and NOD mouse models of MHClinked insulin-dependent diabetes mellitus, in which transfer of disease with BM cells (19) (20) (21) , participation of T cells in disease pathogenesis (22, 23) , and a lack of requirement for genetic abnormality in the target tissue (20) have been identified. BM cells have also been implicated in the transfer or treatment of other autoimmune disease in humans and in animal models (24, 25) , and in the efficient transfer of the delayed hypersensitivity response in rats (26) . Although T effector cells are known to participate in these processes, additional marrow-derived elements such as APC (27) , also are thought to be involved.
